Our findings confirm the incremental prognostic value of hs-Tnl and BNP beyond conventional risk factors, and the superior predictive performance of the combined cardiac biomarkers models in patients with stable CAD without T2DM. This evidence concerns the gene TRIM67 and coronary artery disorder.